Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kleiner Perkins Caufield & Byers
Biotech
Sanofi-backed Expansion nabs $80M for RNA neurodegenerative work
Expansion Therapeutics wants to go up against Dyne, Locanabio in myotonic dystrophy. The Sanofi, Novartis-backed biotech now has $80M for the rivalry.
Kyle LaHucik
Sep 29, 2021 7:00am
ArsenalBio joins next-gen cell therapy field with $85M A round
Oct 17, 2019 7:00am
Kleiner, GV drive gene editing startup Trucode to $34M round
Sep 10, 2019 8:30am
Stroke software builder Viz.ai brings in $21M in series A round
Jul 18, 2018 3:30pm
Tmunity dials series A round up to $135M
Apr 19, 2018 9:15am
Armo taps Celgene, GV for $67M to fuel late-phase I-O R&D
Aug 30, 2017 9:09am
